Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1/2 randomized age-descending study of Shigella4V vaccine in Kenya
PACTR202105845422919Phase 1Recruiting
- Sponsor
- LimmaTech Biologics
- Start
- Sep 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, randomised trial of Shigella4V in shigellosis, sponsored by LimmaTech Biologics. Started Sep 2019; status: recruiting.
02
Drugs
Shigella4V
03
Conditions
shigellosis
Beyond the preview
Go deeper on PACTR202105845422919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202105845422919.